SG. High-fat, lowcarbohydrate diet promotes arrhythmic death and increases myocardial ischemia-reperfusion injury in rats. Am J Physiol Heart Circ Physiol 307: H598 -H608, 2014. First published June 14, 2014; doi:10.1152/ajpheart.00058.2014.-High-fat, low-carbohydrate diets (HFLCD) are often eaten by humans for a variety of reasons, but the effects of such diets on the heart are incompletely understood. We evaluated the impact of HFLCD on myocardial ischemia/reperfusion (I/R) using an in vivo model of left anterior descending coronary artery ligation. Sprague-Dawley rats (300 g) were fed HFLCD (60% calories fat, 30% protein, 10% carbohydrate) or control (CONT; 16% fat, 19% protein, 65% carbohydrate) diet for 2 wk and then underwent open chest I/R. At baseline (preischemia), diet did not affect left ventricular (LV) systolic and diastolic function. Oil red O staining revealed presence of lipid in the heart with HFLCD but not in CONT. Following I/R, recovery of LV function was decreased in HFLCD. HFLCD hearts exhibited decreased ATP synthase and increased uncoupling protein-3 gene and protein expression. HFLCD downregulated mitochondrial fusion proteins and upregulated fission proteins and store-operated Ca 2ϩ channel proteins. HFLCD led to increased death during I/R; 6 of 22 CONT rats and 16 of 26 HFLCD rats died due to ventricular arrhythmias and hemodynamic shock. In surviving rats, HFLCD led to larger infarct size. We concluded that in vivo HFLCD does not affect nonischemic LV function but leads to greater myocardial injury during I/R, with increased risk of death by pump failure and ventricular arrhythmias, which might be associated with altered cardiac energetics, mitochondrial fission/fusion dynamics, and store-operated Ca 2ϩ channel expression.
HIGH-FAT, LOW-CARBOHYDRATE DIETS (HFLCD) have received considerable attention in recent years, having been adopted by many individuals for reasons ranging from taste preference to attempts at weight loss. Although the macronutrient composition of specific HFLCD may vary, in its most extreme form, it may contain a very low carbohydrate content (10% of kilocalories), a relatively high protein content (30% of kilocalories), and a very high amount of saturated and monounsaturated fat (fat constituting 60% of kilocalories), resembling the initial phase of the Atkins diet (20) . These compositions are significantly different from the more familiar "Western diets," which typically are high in both fat and carbohydrates. These Western diets (typically 40 -45% fat, 40 -50% carbohydrate) increase myocardial susceptibility to ischemia and ischemia-reperfusion (I/R) injury (59) and impair systolic function (37) . Although the cardiovascular effects of Western diets have been relatively well studied in animal models, those of HFLCD have not been as well characterized, and the macronutrient composition differences between these diets make it difficult to extend experimental results obtained with the Western diets to the effects caused by HFLCD. Indeed, population studies that directly examined the impact of HFLCD on cardiovascular outcomes have yielded conflicting results, with some showing increased risk of adverse outcomes (32) and others reporting no increased risk (23) . Indeed, such diets may be protective against effects of disease or harmful, depending on the condition studied. For example, animal model studies have shown that high-fat diet (without extreme carbohydrate restriction) alleviated the progression to pressure overload-induced heart failure (42); furthermore, when eaten after an experimental myocardial infarction, a high-fat diet did not lead to worsened left ventricular (LV) dysfunction (49) . On the other hand, in those same series of experiments, administration of high-saturated-fat diet for 2 wk before coronary artery ligation resulted in an increased surgical mortality rate (49) . To our knowledge, there are presently no studies reporting the mechanism of HFLCD diets on the cardiovascular response to I/R, making further investigation important. There is substantial literature investigating the impact of polyunsaturated fatty acids in the treatment of arrhythmias including atrial fibrillation (64) . However, very few studies have assessed the role of very high saturated and monounsaturated fatty acid-containing diets in arrhythmogenesis and the cardiovascular response to I/R, also making further investigation important.
The link between dietary fatty acid, mitochondrial morphology, and mitochondrial Ca 2ϩ cycling is an understudied area. Some studies have shown that HFLCDs (55-60% fat, 16 -20% carbohydrate) increase cardiac mitochondrial fatty acid oxidation and uncoupling, thereby decreasing energy efficiency, and cause extensive mitochondrial structural abnormalities, including swelling, loss of cristae, and disruption of inner and outer membranes, resulting in vacuolization and deformation in ventricular myocytes (13, 25) . Under normal conditions, cardiomyocytes and their mitochondria are able to utilize a variety of fuel substrates by oxidative metabolism to generate ATP; however, this metabolic flexibility may be altered by diet. Indeed, a previous study has demonstrated adverse effects on glucose metabolism and insulin sensitivity following feeding with HFLCD (4), whereas at least one human study has shown beneficial effects in patients with type 2 diabetes (31). Although mitochondria are mainly recognized for their role in energy metabolism, they have a number of other functions as well. Mitochondria continually may undergo fusion and fission [regulated by proteins including mitofusin-1, 2 (Mfn1, 2), optic atrophy 1 (Opa1), dynamin-related protein 1 (Drp1), and fission1 (Fis1)], and these processes affect mitochondrial DNA stability, respiratory capacity, response to cellular stress, and mitophagy (7, 44) . Mitochondrial derangements may also lead to lethal arrhythmias through activation of a number of ion channels under conditions of oxidative stress (1, 6) . As an example, there is emerging interest in the stromal interaction molecule-1 (STIM1)/Orai-mediated store-operated Ca 2ϩ entry (SOCE), which facilitates the influx of Ca 2ϩ from the extracellular space, resulting in a sustained increase in cytosolic Ca 2ϩ levels, and refills the calcium stores of the sarcoplasmic reticulum (SR) (14) . A recent study in the intact heart showed that, during early reperfusion, there was a significant drop in SR Ca 2ϩ and a shortening of phase 2 action potential duration, which might be a trigger for STIM1 oligomerization and provide a clue to explain early reperfusion arrhythmias (60) . The effects of HFLCD on all these functions, and, in particular, how these diets may interact with physiological stress such as I/R injury to affect these cellular functions have not been characterized.
On the basis of our previous work using an isolated heart model to study the cardiovascular effects of HFLCD on I/R (61) and to address these questions, we hypothesized that HFLCD impairs cardiac function and predisposes to ventricular arrhythmia during I/R stress through the modulation of key genes of fatty acid oxidation, efficiency of ATP production, mitochondrial fusion and fission, and possibly store-operated calcium channel regulation. To test this hypothesis, we employed an in vivo rat model of left anterior descending coronary artery (LAD) ligation and reperfusion, analyzing the effect of HFLCD on cardiac function, heart rhythm, and regulation of genes and proteins involved in mitochondrial uncoupling, transport and oxidation of fatty acids, ATP production, fission/fusion dynamics, and store-operated calcium ion channel regulation.
METHODS
Ethics statement. Animal experiments were approved by the Institutional Animal Care and Use Committee of the University of Alabama at Birmingham and followed the Guide for the Care and Use of Laboratory Animals (National Academy of Sciences, 1996) .
Animal and diets. Twelve-week-old, 300-g male Sprague-Dawley rats (Taconic Farms, Hudson, NY) were fed one of two diets designed similar to ones used by humans for weight loss: HFLCD (60% calories from fat, 30% from protein, 10% from carbohydrate; 5TSY; TestDiet, Richmond, IN) or a low-fat control diet (CONT; 16% fat, 19% protein, 65% carbohydrate; TestDiet 5TJM) for 2 wk. HFLCD had higher energy density than CONT (5.0 vs. 3.9 kcal/g); the source of macronutrients in the diets was listed previously (34, 61) . Among the total amount of fat present in each diet, both diets were designed to contain 40% saturated fatty acids (as a percentage of total fat), 40% monounsaturated fatty acids, and 20% polyunsaturated fatty acids (Table 1) ; the makeup is designed to be similar to the induction phase of the Atkins diet for humans (20) , with macronutrient content high in protein, low in carbohydrate, and 4.8-fold higher in fat than the CONT diet. The rats were housed at 22°C on a 12-h:12-h light/dark cycle. Animals were allowed ad libitum access to food and water.
Body weight and body composition. Weight gain and food intake were monitored once a week. Body composition (% body fat, %BF) was determined using Dual-Energy X-ray Absorptiometry scan (DXA; General-Electric Lunar Prodigy, Madison, WI). At time of animal death, the fat pad masses, including interscapular, inguinal, subcutaneous, retroperitoneal, gonadal, and mesenteric adipose tissue, were dissected carefully and weighed.
Tissue preparation hematoxylin eosin and oil red O staining. After anesthesia with 4% isoflurane, the rats were killed. The rat hearts were perfused with cardioplegic buffer containing 20 mmol/l KCl for 1 min. The hearts were excised and embedded in optimal-cuttingtemperature compound, frozen in liquid nitrogen, and then stored at Ϫ80°C until sectioning. Serial 5-15-m-thick sections were obtained using a sliding microtome (HM505 E; Microm, Waldorf, Germany). For histological analysis, these sections were collected on gelatincoated slides, stained with hematoxylin eosin and oil red O.
Echocardiography. Rats were anesthetized with 2% isoflurane, and echocardiography (using an Agilent Sonos 5500; Philips, Bothell, WA) was performed as previously described (40) . A two-dimensional short-axis view and M-mode tracings of the LV were obtained with a 60-MHz transducer (35) .
Open-chest myocardial I/R. We used an in vivo I/R model. The chest was opened via a left thoracotomy through the fourth or fifth intercostal space, and the ribs were gently retracted. After pericardiotomy, a 6/0 Proline (Ethicon, Bridgewater, NJ) ligature was placed under the LAD, and the ends of the suture were threaded through a small plastic (PE-50) tube to form a snare for reversible coronary artery occlusion. Rats were stabilized for about 20 min (baseline), followed by 30-min LAD occlusion (attained by tightening and clamping the snare) and 120-min reperfusion (I/R). A PE-50 catheter was placed from the right carotid artery into the LV to monitor cardiac function and in the femoral artery to record blood pressure throughout the procedure (DASYLab; Measurement Computing, Norton, MA; n ϭ 6 to 7 for each diet). Heart rate (HR), systolic pressure (SP), LV end diastolic pressure (LVEDP), and peak positive and negative rates of change of pressure (ϩdP/dt and ϪdP/dt) were used as indices of ventricular function. From these values, the rate-pressure product [RPP ϭ (SP Ϫ LVEDP) ϫ HR] was computed as the index of cardiac power. Recovery during the last 20 min of reperfusion was expressed as a percentage of baseline values.
After the end of reperfusion, the heart was excised, and Evan's blue dye was infused into the proximal stump of the aorta with the LAD snare tightened to define the area at risk (i.e., the area not stained with blue dye). Hearts (n ϭ 4 to 6 for each diet) were then sectioned, stained with 1% triphenyltetrazolium chloride and photographed, and the infarct and risk zones were quantified by Image J. A sham group (n ϭ 5 for each diet) was also done; in these, all aspects of the I/R protocol were carried out, except that the occluder was not tightened. Data from sham animals were included when calculating the dietgroup averages for body weight and resting (nonischemic) cardiac function. ECG monitoring was performed throughout the experiment with an electrode on each forepaw, with the ECG potential recorded (Chart 4.0; AD Instruments, Colorado Springs, CO). Arrhythmias (ventricular fibrillation, tachycardia) were determined from inspection of the ECG recording. An arrhythmic event was defined by the appearance of more than five successive ventricular extrasystoles or disorganized ventricular activity.
Myocardial triglyceride content. Myocardial triglyceride content was biochemically assayed using an established method (9) . LV tissue (50 -100 g) was homogenized in an ice-cold methanol/chloroform/ water mixture (2:1:0.8), vortexed, and centrifuged to separate the organic and aqueous layers. The chloroform layer was evaporated, the residue dissolved in methanol, and triglycerides assayed using LiquiColor Test (Stanbio Laboratory, Boerne, TX).
Protein and transcript analysis. Protein samples were extracted from heart tissue (n ϭ 4 to 5 for each diet). Western blots were conducted using commercial antibodies: carnitine palmitoyltransferase (CPT1B, CPT2), uncoupling proteins (UCP2, UCP3) (Alpha Diagnostic, San Antonio, TX); ATP synthase (MitoSciences, Eugene, OR); Mfn1, Opa1, GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA); Fis1, Drp1 (Thermo Fisher Scientific, Rockford, IL); Mfn2 (Abcam, Cambridge, MA); STIM1 (Cell Signaling Technology, Danvers, MA); and Orai1, Orai3 (ProSci, Poway, CA). Total RNA samples were extracted from LV of these same rats using an RNA extraction kit (Qiagen, Gaithersburg, MD) and cDNA synthesized using cDNA synthesis kit (Clontech, Mountain View, CA) according to the manufacturer's instructions. Quantitative RT-PCR analyses were carried out using the Roche SYBR green LightCycler 480 system (Roche, Indianapolis, IN). RT-PCR results from each gene were normalized to GAPDH transcript levels. The primers used are listed in Table 2 .
Statistical analyses. Data were analyzed using two-way ANOVA and/or unpaired t-test, as appropriate (Prism; GraphPad Software, La Jolla, CA). Values were expressed as means Ϯ SE. The proportions of animals surviving and proportions with ventricular arrhythmias were compared using Fisher's exact test. Differences between groups were regarded as significant at the P Ͻ 0.05 probability level.
RESULTS

Effect on baseline LV function, body weight, and body composition.
Echocardiographic assessment in closed-chest animals (without sternotomy) revealed that hearts from rats fed HFLCD exhibited smaller end systolic dimension with similar end-diastolic dimension compared with CONT; dietary effect on LV volumes, ejection fraction, and fractional shortening did not reach statistical significance (Table 3) . Before initiation of ischemia, LV systolic and diastolic function was similar between diet groups as assessed by LV catheter measurement after thoracotomy/pericardiotomy (Table 4) .
Body weight increased to a greater extent in rats fed HFLCD diets for 2 wk compared with those fed CONT (395 Ϯ 4 vs. 361 Ϯ 7 g, P Ͻ 0.01, n ϭ 22-28 each group), which are very similar to our previously reported findings using same-age rats Table 2 . Rat primers used in the present study (Fig. 1) . RPP and ϮdP/dt recovery were decreased by 40 -50%, compared with CONT (Fig. 1, A and B) , and LVEDP was about 1.4-fold greater than CONT at the end of reperfusion (Fig. 1C) . HR was not different between the two groups. For all these LV functional parameters, two-way ANOVA demonstrated a significant effect of diet and of I/R status with HFLCD showing a worse outcome than CONT and I/R with worse performance than sham (P Ͻ 0.05 for diet and for I/R status; no significant interaction).
All sham rats survived the protocol, and there were no detected ventricular or atrial arrhythmias in the sham group, with either diet. However, a number of rats did not survive the I/R protocol: 6 of 22 CONT rats and 16 of 26 HFLCD rats died during either coronary artery occlusion or before 120 min of reperfusion was completed. The survival rate was lower in HFLCD (P Ͻ 0.05 by Fisher's exact test, Fig. 2A) . Analysis of mode of death revealed that HFLCD animals died of both ventricular arrhythmia (12 of 16 deaths) as well as pump failure (4 of 16), whereas all deaths in the CONT group (6 out of 6) were due to progressive hypotension. HFLCD-fed rats often showed ventricular fibrillation just before death. In all cases, onset of ventricular arrhythmias on the ECG corresponded to acute drop of blood pressure. Figure 2B shows examples of representative heart rhythm abnormalities. Among rats surviving the 30 min of ischemia and in which reperfusion was initiated (n ϭ 20 CONT, n ϭ 16 HFLCD), the number of ventricular arrhythmias occurring in rats fed HFLCD was greater than in rats fed CONT diet (6.6 Ϯ 2.6 vs. 0.5 Ϯ 0.4 events per rat, P Ͻ 0.05). The percentage of animals with ventricular arrhythmias and the average duration of such arrhythmias per rat were higher in HFLCD than in CONT (P Ͻ 0.05 by Fisher's exact test for percentage with arrhythmia, P Ͻ 0.05 by unpaired t-test for average duration of events per rat, Fig. 2C ). Figure 2D shows two examples of representative LV pressure recordings: one in a CONT diet animal demonstrating survival to protocol completion, and another pressure recording showing death by progressive pump failure/shock in a HFLCD animal.
HFLCD increases myocardium infarct area after I/R.
In rats surviving to 120 min of reperfusion, HFLCD led to threefold larger infarct area (expressed as percentage of area at risk), demonstrating greater ischemic injury in HFLCD. This was also associated with a larger area at risk compared with CONT (Fig. 3) .
Oil red O staining and myocardial triglyceride content. Oil red O staining showed focal lipid deposition in HFLCD hearts but not on CONT heart sections. Biochemical assay of triglyceride content showed a trend toward increased triglyceride in HFLCD that did not reach statistical significance (P ϭ 0.077) (Fig. 4) .
Effects of HFLCD on indices of myocardial energy metabolism following I/R. Regulation of gene expression by nutrients
in mammals is an important mechanism allowing them to adapt to the nutritional environment (52) . Transcript levels of some representative genes involved in fatty acid oxidation, such as long-chain and medium-chain Acyl CoA dehydrogenase (ACADL and ACADM), were upregulated in hearts of HFLCD compared with CONT. There was no change of transcript levels of CD36, malonyl-CoA decarboxylase, CPT1B or CPT2. Transcript of UCP3 was upregulated in myocardium from HFLCD hearts, whereas ATP synthase transcript was downregulated (Fig. 5A) . Transcript levels of some representative genes involved in glucose uptake and oxidation, such as glucose transporter type 1 (GLUT1) were downregulated in hearts of HFLCD compared with CONT. There was no change of transcript levels of GLUT4, pyruvate dehydrogenase kinase isozyme 4, phosphofructokinase C, and type II hexokinase (Fig. 5A ). Protein expression of CPT1b and CPT2 was not affected by diet, whereas HFLCD hearts exhibited decreased ATP synthase and increased UCP3 protein expression (Fig. 5B) .
HFLCD inhibits mitochondrial fusion and increases fission following I/R. There were no changes in Mfn1, Mfn2, Opa1, and Drp1 mRNA expression, but fission regulator Fis1 transcript expression was upregulated by ϳ60% in HFLCD relative to CONT hearts following I/R (P Ͻ 0.05; Fig. 6A) . At the protein level, there was a diet effect on several of these regulators: Western blots revealed that myocardial Mfn1 and Mfn2 protein contents decreased by 7-18%, whereas Fis1 and Drp1 protein increased 17-23% in HFLCD compared with CONT (P Ͻ 0.05 for all; Fig. 6B ). HFLCD upregulates store-operated Ca 2ϩ channels following I/R. Mfn2 connects neighboring mitochondria and also tethers mitochondria to the proximal SR, forming a juxtaposition required for efficient mitochondrial Ca 2ϩ uptake and energy production (15, 18) . The observed effect of HFLCD on Mfn2 prompted us to study whether HFLCD affects proteins known to regulate SOCE. Cardiac STIM1 and Orai3 mRNA and protein levels were upregulated in HFLCD (P Ͻ 0.05; Fig.  7, A and B) , whereas the differences in Orai1 mRNA (P ϭ 0.07) and protein (P ϭ 0.32) did not reach significance.
DISCUSSION
Diets with macronutrient composition similar to the HFLCD we used in this work have become quite popular among humans and are eaten for a variety of reasons. Here, using a physiologically relevant model of myocardial ischemia/infarction, we demonstrate that even very brief, 2-wk consumption of this diet is associated with a number of adverse effects on the heart. The in vivo model of LAD ligation is a well-accepted experimental protocol, which circumvents some of the limitations of the isolated heart model (29) and more accurately reflects the clinical impact of an acute coronary syndrome. We found that HFLCD did not affect LV systolic and diastolic function under baseline "nonstress" conditions as evaluated by in vivo echocardiography and catheter hemodynamic measurements, whereas, in the presence of in vivo myocardial I/R, HFLCD led to lower recovery of cardiac function and larger infarct size, with increased risk of ventricular arrhythmias and death. Although there was a trend for both fractional shortening and ejection fraction to be increased under nonstress conditions, this may not necessarily be beneficial; there are a number of conditions of the LV in which a normal or hyperdynamic ventricle is associated with pathology, including hypertrophic cardiomyopathy or hypertensive heart disease. The addition of the pathological stress here may be unmasking underlying myocardial abnormalities. These results are consistent with our prior work using isolated heart models (34, 61). Interestingly, Chandler's group made mention of significant surgical mortality in rats fed a high-fat diet for 2 wk and then subjected to I/R coronary ligation surgery but did not further explore this finding, as it was not the main subject of their paper (49); here we have examined this effect in more detail.
The full array of mechanisms leading to greater myocardial injury in HFLCD is not unequivocally proven. Although biochemical measurement did not definitively show increased myocardial fat, oil red O staining on frozen heart sections demonstrated lipid droplets in HFLCD but none in CONT hearts; our observation is in agreement with the other report that high-fat diet induced myocardial lipid accumulation in rats (45) , possibly suggesting cardiac steatosis, which is well known to be detrimental (12, 53) . Meanwhile, the direct effects of HFLCD upregulated peroxisome proliferator-activated receptor-␣-target genes of UCP3, ACADL, and ACADM expression; this is in line with other studies demonstrating that consumption of somewhat similar diets (60% fat and 21% carbohydrate) increases the expression of enzymes involved in fatty acid oxidation (10, 22, 41) . These findings suggest the possibility of an increase in fatty acid oxidation in the HFLCD heart. Although we did not measure oxidation rates, nutrient excess from high-fat diet may result in the accumulation of toxic intermediates of fatty acid metabolism, some of which were shown to be a result of incomplete mitochondrial fatty acid oxidation and contribute to impaired insulin signaling and to decreased glucose oxidation (30, 53) and greater oxidative stress and endoplasmic reticulum stress (36) . Therefore, any abnormalities of fatty acid oxidation in HFLCD might lead to worsened cardiac function during I/R, whereas repressing myocardial fatty acid oxidation has been proposed as a therapeutic target to improve cardiac efficiency in the ischemic heart (57). On the other hand, GLUT1 plays a significant role in myocardial glucose uptake and cardiac glucose metabolism, and overexpression of cardiac-specific GLUT1 reverses the deleterious effects of excessive fatty acid oxidation during heart I/R and protects against aging-associated increase of susceptibility to ischemic injury (38) . Our results show that GLUT1 gene expression is significantly downregulated in HFLCD after I/R, which might lead to a worsening of I/R outcome. A host of metabolic factors, such as availability of substrate and the hormonal milieu, may be important in determining the diet effect here. We have previously shown that the plasma metabolic parameters found in rats after these same diets for a 2-wk duration resulted mainly in lower fed-state insulin in HFLCD, with higher ketone bodies; diet did not affect the circulating glucose, lactate, free fatty acid, or triglycerides; the differences in circulating insulin and insulin effect may impact a number of myocardial processes (61) . Nutrient supply and demand imbalance might also have effects on myocardial mitochondrial dynamic balance between fusion and fission as an important mechanism to maintain normal mitochondria number and function (39) . Changes to nutrient availability and energy demand particularly for the state of nutrient excess high fat can divert mitochondria from the life cycle and extend their stay in the postfission state (fragmentation) (33) . Although the fission-fusion dynamic has never been observed in real time in adult cardiomyocytes because of its extremely slow turnover rate of 14 -16 days (8) and needs further exploration, altered mitochondrial morphology and network structure have been implicated to be associated with the progression of heart failure (47), whereas inhibiting fission protects the heart against I/R injury (43) . Our results show that HFLCD led to downregulation of fusion proteins and upregulation of fission proteins, which are consistent with observations of Kiki et al. (28) . This altered balance (toward fission) attributable to HFLCD combining with ATP synthase expression downregulation might further impair mitochondrial efficiency and cardiac contractile function.
One of the most interesting findings of our study was that, during the coronary artery occlusion and reperfusion phases, rats fed HFLCD exhibited more arrhythmic events and a higher mortality, often with ventricular fibrillation causing death. This only occurred in the HFLCD group and only occurred during I/R; there were no signs of electrical abnormalities under baseline conditions. The present data are consistent with other studies demonstrating that high-fat diet resulted in increased ventricular extrasystoles during I/R with increased death secondary to ventricular fibrillation (3, 46) . Despite these potential contributing factors, the precise mechanisms that lead to ventricular arrhythmias during I/R are not fully understood. We have identified several abnormalities whereby HFLCD may contribute to ventricular arrhythmias and sudden death. First, arrhythmias frequently occur in hearts with metabolic derangement. Saturated fatty acids may increase cardiovascular risk and increase susceptibility to ventricular fibrillation and tachycardia after I/R (19, 50) . There has also been interest in use of n-6 and n-3 polyunsaturated fatty acids to lower the risk of sudden cardiac death and prevention of reperfusion arrhythmias (11, 16) although recent clinical prevention and animal studies have not borne this conjecture out (5, 17) . HFLCD is enriched with all types of fatty acids, which might promote metabolic and electric instability, thereby leading to ventricular arrhythmias during I/R. Second, we found that STIM1 and Orai3 were upregulated in HFLCD. Pharmacological modulation of the Orai calcium channels provokes ventricular arrhythmias (62, 63) . Abnormalities leading to increased mitochondrial calcium (including I/R) may potentiate arrhythmias possibly through this mechanism (14, 54) . Arrhythmic conditions are associated with systemic and cardiac oxidative stress (2, 26) , and, previously, we reported increased myocardial oxidative stress attributable to HFLCD (34) . In response to oxidative stress, STIM1 results in increased SOCE and altered mitochondrial Ca 2ϩ homeostasis and bioenergetics (24) . Moreover, Mfn2 is involved in regulation of STIM1 trafficking, with lower Mfn2 resulting in increased Ca 2ϩ entry (55) , which may be involved in development of ventricular fibrillation (27) . Thus HFLCD-induced Mfn2 downregulation potentially leads to STIM1 and Orai-mediated Ca 2ϩ overload, with store-operated Ca 2ϩ channels playing a role in the increase in arrhythmias with HFLCD. Third, we demonstrated that HFLCD upregulated UCP3. Pharmacological uncoupling of the mitochondria increases the interventricular action potential duration and conduction velocity heterogeneity, promoting ischemia-induced ventricular arrhythmias (56); impairment in ATP production with HFLCD might lead to ventricular arrhythmias. Downregulation of mitochondrial ATP synthase subunit 6 was observed in hearts with ventricular fibrillation during I/R (58). ATP depletion is related to collapse of the mitochondrial inner membrane potential causing arrhythmic propensity in cardiac tissue (65) . Finally, the larger infarct size with HFLCD may provide an alternate explanation for the increase in ventricular arrhythmias and sudden death because large infarcts or more severe ischemia may be more likely to predispose to these arrhythmias (51) .
We note some important limitations of the present study. First, we did not directly perform mitochondrial respiration studies, enzyme activity, and phosphorylation status assays, instead using transcript levels and protein expression of relevant pathway proteins as an index. The gene expression and protein levels alone are not the only drivers of mitochondrial function and myocardial energetics. Prior work by Chandler's group, has demonstrated that high dietary fat (60%) decreases myocardial mitochondrial respiration, in the setting of increased ACADM activity (48); therefore, we expect similar effects in our animals. Secondly, the HFLCD and CONT diets we used have different amounts of protein, limiting the ability to determine just how much of the effect was attributable to fat alone. However, our intent was not to examine the fat effect in isolation but rather to determine the overall effect of a diet similar to the type often used by humans. A concern is that the higher protein content in HFLCD might adversely affect kidney function. However, a clinical trial in humans showed that low-carbohydrate, high-protein diet over 2 yr was not associated with harmful effects on renal function (21) . To further address the separate impact of protein, fat, and carbohydrate in the diets, we propose future experiments with an array of diets controlling for each of these macronutrients.
In summary, we found that feeding rats HFLCD did not alter the resting (nonischemic) cardiac function, but even just a brief, 2-wk duration of feeding with HFLCD resulted in impaired recovery of function following I/R using this in vivo model designed to replicate the effects of a myocardial infarction. This was also associated with a greater incidence of potentially fatal ventricular arrhythmias and death by both arrhythmia and cardiac failure. Although several mechanisms for these abnormalities may exist, we demonstrate that HFLCD adversely affects a number of pathways, including key regulators of cellular energy metabolism, mitochondrial dynamics, and SOCE, all of which are known to be associated with harmful effects on the heart and which might play a role.
